A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
Clinical trial NCT02133404 · COMPLETED
Trial details
- NCT number
- NCT02133404
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-14
- Primary completion
- 2014-11-10
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.